{"transactions":[{"id":4225233,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":173624,"kind":"person","name":"Rowlinson Scott W","position":1,"cik":"0001655979","reported_name":"Rowlinson Scott W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-08-24T22:02:15.000Z","date":"2017-08-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 50% of the shares subject to the option on August 22, 2018, an additional 30% of the shares subject to the option on August 22, 2019, and the remaining 20% of the shares subject to the option on August 22, 2020, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":3.1,"expiration_date":"2027-08-21","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001140361-17-033206","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636282/000114036117033206/doc1.xml","form_type":"4"}},{"id":4374286,"issuer":{"id":2649,"kind":"organization","name":"Spyre Therapeutics, Inc.","symbol":"SYRE"},"owners":[{"id":173624,"kind":"person","name":"Rowlinson Scott W","position":1,"cik":"0001655979","reported_name":"Rowlinson Scott W","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-03-22T20:54:30.000Z","date":"2017-03-20","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning on April 20, 2017, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":60000,"derivative":{"exercise_price":8.03,"expiration_date":"2027-03-19","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001140361-17-012949","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636282/000114036117012949/doc1.xml","form_type":"4"}}]}